» Articles » PMID: 29332647

Social Support a Key Factor for Adherence to Multidrug-resistant Tuberculosis Treatment

Overview
Journal Indian J Tuberc
Publisher Elsevier
Date 2018 Jan 16
PMID 29332647
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multidrug-resistant tuberculosis (MDR-TB) is emerging as a major public health problem globally. Treatment success rates in MDR-TB across the globe are not encouraging as completing MDR-TB treatment successfully is challenging due to high proportion of lost to follow up.

Methods: Using qualitative methods and grounded theory approach, in-depth interviews were conducted with MDR-TB patients and treatment providers. The social cognitive framework was explored as a way to guide understanding of the factors affecting treatment adherence among MDR-TB patients.

Results: Multiple factors influenced patient's decision to adhere to MDR-TB treatment. Self-motivation, awareness about disease and treatment, counselling support, family support, nutritional support and social support were important drivers for successful treatment. Providers related that motivational counselling, nutritional support, family support and social support encouraged treatment adherence.

Conclusion: To improve MDR-TB treatment adherence, a patient-centric approach should be considered at the programmatic level. There is a need to formulate strategy that includes motivational counselling, nutritional supplementation and social support mobilisation for treatment adherence. Participants suggested a Patient Support Group led treatment care model for better adherence and treatment success rates in MDR-TB treatment.

Citing Articles

The effects of stigma and social support on the health-related quality of life of people with drug resistance tuberculosis in Lagos, Nigeria.

Adejumo O, Jinabhai C, Daniel O, Haffejee F Qual Life Res. 2025; .

PMID: 39964366 DOI: 10.1007/s11136-025-03902-5.


Perceived Social Support and Medication Dose Interruption Among Pulmonary Tuberculosis Patients in Western India: A Cross-Sectional Study.

Ahuja N, Kuzmik A, Sznajder K, Lengerich E, Fredrick N, Chen M Cureus. 2024; 16(11):e74507.

PMID: 39726449 PMC: 11670805. DOI: 10.7759/cureus.74507.


A Mixed-Method Study of Medication-Related Burden Among Multi-Drug Resistant Tuberculosis Patients in West Java, Indonesia.

Ausi Y, Yunivita V, Santoso P, Sunjaya D, Barliana M, Ruslami R Clinicoecon Outcomes Res. 2024; 16:707-719.

PMID: 39345348 PMC: 11438463. DOI: 10.2147/CEOR.S473768.


Design and prototype of TOMO: an app for improving drug resistant TB treatment adherence.

Fuad A, Herwanto G, Pertiwi A, Wahyuningtias S, Harsini H, Maula A F1000Res. 2024; 10:983.

PMID: 39234577 PMC: 11372341. DOI: 10.12688/f1000research.67212.1.


Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea.

Lee S, Lee J, Ji H, Lee J, Park S, Han C Int J Health Policy Manag. 2024; 13:8262.

PMID: 39099483 PMC: 11365073. DOI: 10.34172/ijhpm.8262.